See All Slides - tctmd.com

Slides

Presentation

Association of Stent Indication with Post-Operative Outcomes Following Noncardiac Surgery

Presenter: Carla Holcomb

December 29, 2015

Presentation

Warning Symptoms are Associated with Survival from Sudden Cardiac Arrest

Presenter: E. Marijon

December 27, 2015

Presentation

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Presenter: William Wilson

December 22, 2015

Presentation

Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT

Presenter: Larry R. Jackson

December 21, 2015

Presentation

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Presenter: Ted Feldman

December 21, 2015

Presentation

Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy

Presenter: MB. Kadakia

December 20, 2015

Presentation

Enrollment Volume Effect on Risk Factor Control and Outcomes in the SAMMPRIS Trial

Presenter: David Chiu

December 17, 2015

Presentation

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Presenter: PA. Gurbel

December 16, 2015

Presentation

Effect of Availability of TAVR on Clinical Practice

Presenter: Jochen Rein?hl

December 15, 2015

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

Advertisement

Slides

Association of Stent Indication with Post-Operative Outcomes Following Noncardiac Surgery

Warning Symptoms are Associated with Survival from Sudden Cardiac Arrest

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy

Enrollment Volume Effect on Risk Factor Control and Outcomes in the SAMMPRIS Trial

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Effect of Availability of TAVR on Clinical Practice

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content